Association of hair loss with variation of blood components such as red blood cells, thyroid hormones in young wome
Not Applicable
- Conditions
- Health Condition 1: L650- Telogen effluvium
- Registration Number
- CTRI/2022/06/043154
- Lead Sponsor
- Shilpa A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All female patients of age 18-45 years with clinical diagnosis of Telogen effluvium
Patients willing to participate in the study
Exclusion Criteria
Patients with other causes of diffuse hair loss
Patients with other comorbidities and on chemotherapy
Patients not willing to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method